This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Michigan State University, Vanderbilt University. Active years: 2018-2022.
Company Filing History:
2 out of 1,438 
1 out of 1,218 
Years Active: 2018-2022
Title: Caryl E Sortwell: Innovator in Parkinson's Disease Research
Introduction
Caryl E Sortwell is a prominent inventor based in Grand Rapids, MI (US). She has made significant contributions to the field of neuroscience, particularly in the study and treatment of Parkinson's disease. With a total of 2 patents, her work focuses on improving therapeutic responses for patients suffering from this debilitating condition.
Latest Patents
Caryl E Sortwell's latest patents include groundbreaking methods and compositions aimed at enhancing treatment options for Parkinson's disease patients. One of her notable inventions is related to predicting therapeutic response in Parkinson's disease. This patent provides methods for determining the susceptibility of patients to optimized drug therapy (ODT) and deep brain stimulation (DBS) therapy. Another significant patent addresses Nurr1 as a genetic target for treating levodopa-induced dyskinesias in Parkinson's disease. This invention outlines methods for treating movement disorders by reducing the activity of Nurr1, particularly in subjects who have developed or are at risk of developing levodopa-induced dyskinesia (LID).
Career Highlights
Caryl E Sortwell has had a distinguished career, contributing to the advancement of medical research and treatment methodologies. She has worked at reputable institutions, including Michigan State University and Vanderbilt University, where she has collaborated with other experts in the field.
Collaborations
Caryl has collaborated with notable colleagues such as Jack W Lipton and Nicholas Kanaan, further enhancing her research and contributions to the scientific community.
Conclusion
Caryl E Sortwell's innovative work in the field of Parkinson's disease research exemplifies her dedication to improving patient outcomes. Her patents and collaborations reflect her commitment to advancing medical science and providing hope for those affected by this condition.